Navigation Links
Exiqon Announces New Grant Program for MicroRNA Research

Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the launch of a new research grant program, open to researchers from academic and non-profit institutions across North America.

(PRWEB) May 15, 2009 -- Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the launch of a new research grant program, open to researchers from academic and non-profit institutions across North America.

"We are excited to offer this type of financial support to the research community at-large. Scientists are making ground-breaking discoveries in the field of microRNA research every day, with implications for human medicine in the form of new insights, new therapies and new diagnostics. Now, more than ever, we recommit ourselves to the success of our customers," says Erik Holmlin, Chief Commercial Officer, Exiqon A/S.

The Exiqon Grant Program has been established with an internal seed funding of $25,000, from which awards will be given to researchers to drive projects enhancing the understanding of how microRNA expression and function relates to normal cellular development, and/or disease-related cellular pathways.

Recipients may use Exiqon Grant Program awards for the purchase of any Exiqon microRNA product or service. Exiqon offers a complete product line for microRNA investigation, including products for RNA isolation, Microarray analysis, qRT-PCR analysis, Northern Blotting, In Situ Hybridization, and Knockdown studies. Exiqon also offers microRNA profiling services for both microarray and qRT-PCR analysis, complete with full sample QC and customized data analysis and reporting.

Researchers are invited to submit an abstract, outlining their research area, project goals, and proposed workflow no later than Monday, June 15th, 2009. Award conveyance through the Exiqon Grant Program does not influence, and is not influenced by, any other existing or potential sources of project funding.

Applications are due June 15th, 2009, and may be submitted electronically via a special Grant Program webpage, Grant recipients will be announced no later than July 1st, 2009.

Chris Harbert
Exiqon, Inc.
888 647 2879


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO
2. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
3. Standard & Poors Announces Changes to U.S. Index
4. WuXi PharmaTech Announces First-Quarter 2009 Results
5. MAP Pharmaceuticals Announces Presentations at the American Thoracic Society International Conference
6. Select Medical Corporation Announces Results for First Quarter Ended March 31, 2009
7. Human Pheromone Sciences Announces First Quarter Results
8. CorVel Announces Fiscal Year Earnings Release Webcast
9. Robert F. Kennedy, Jr. Announces New Food Allergy Initiative Advocacy Steering Committee
10. UTSA announces funding for new faculty research
11. Nektar Announces UCBs Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Post Your Comments:
Related Image:
Exiqon Announces New Grant Program for MicroRNA Research
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
Breaking Medicine Technology: